{"id":47805,"date":"1999-01-08T00:00:00","date_gmt":"1999-01-08T06:00:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/"},"modified":"2022-08-29T10:59:24","modified_gmt":"2022-08-29T15:59:24","slug":"unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/","title":{"rendered":"UNMC Researchers to Study Thalidomide as Treatment\n\nfor Alzheimer&#8217;s Disease"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\"><p><\/FONT><\/B><\/p>\n<p><P>The University of Nebraska Medical Center has begun a six-month research<\/p>\n<p>project to test thalidomide as a possible treatment for people with Alzheimers<\/p>\n<p>disease. In the 1960s, the drug was known for causing severe birth defects.<\/p>\n<p>It was recently approved by the U.S. Food and Drug Administration as a<\/p>\n<p>treatment for a skin condition associated with leprosy.<\/p>\n<p><P>This will be the first collaborative study for Alzheimers disease patients<\/p>\n<p>involving basic and clinical researchers associated with the UNMC Center<\/p>\n<p>for Neurovirology and Neurodegenerative Disorders. The purpose of the center<\/p>\n<p>is to combine clinical and basic research efforts in diseases of the brain<\/p>\n<p>&#8212; such as AIDS and Alzheimer&#8217;s disease &#8212; that can lead to dementia.<\/p>\n<p><P>Co-principal investigators of the study are William Burke, M.D., professor<\/p>\n<p>of psychiatry and director of the division of geriatric psychiatry, and<\/p>\n<p>Howard Gendelman, M.D., director of the UNMC Center for Neurovirology and<\/p>\n<p>Neurodegenerative Disorders and professor of pathology\/microbiology. Dr.<\/p>\n<p>Burke also is co-director, chief of clinical affairs and director of Alzheimers<\/p>\n<p>disease research for the center.<\/p>\n<p><P>Thalidomide is a natural for this study, Dr. Burke said. It is a<\/p>\n<p>potent modifier of the immune system. It turns off the cells in the brain<\/p>\n<p>that produce harmful chemicals that can destroy nerve cells.<\/p>\n<p><P>Ten patients will be enrolled in the six-month study to test the efficacy,<\/p>\n<p>tolerability and safety of thalidomide. Patients will be randomly assigned<\/p>\n<p>to receive either a placebo or 100 or 200 mg. of thalidomide. Participants<\/p>\n<p>will be evaluated at an initial meeting, then again at six weeks, and three-<\/p>\n<p>and six-month follow-up visits. The study is sponsored by Celgene, the<\/p>\n<p>company that manufactures thalidomide.<\/p>\n<p><P>Inflammation appears to be a common pathway to brain degeneration in<\/p>\n<p>Alzheimers disease and AIDS-related dementia. More than 17 epidemiological<\/p>\n<p>studies have shown that patients who take anti-inflammatory drugs may be<\/p>\n<p>at lower risk for Alzheimers.<\/p>\n<p><P>While its not clear which anti-inflammatory agents appear to reduce<\/p>\n<p>risk, it appears the agents may have a role in disease modification and<\/p>\n<p>prevention, Dr. Burke said. This study will help us determine if thalidomide<\/p>\n<p>effects inflammation and degeneration of nerves in the brain associated<\/p>\n<p>with Alzheimers disease.<\/p>\n<p><P>These patients will have significant memory problems and will have<\/p>\n<p>begun to experience difficulty in functioning independently, Dr. Burke<\/p>\n<p>said. We want to be able to measure an improvement in the patients functional<\/p>\n<p>activity and non-cognitive behaviors over a six-month time period.<\/p>\n<p><P>One of the most interesting aspects of this study is the use of proton<\/p>\n<p>magnetic resonance spectrometry (MRS) to test the effectiveness of thalidomide<\/p>\n<p>in a non-invasive way.<\/p>\n<p><P>The novel use of MRS is most exciting, Dr. Burke said. James McConnell,<\/p>\n<p>M.D., associate professor, radiology, will conduct the MRS procedures.<\/p>\n<p><P>MRS measurement techniques, which were developed earlier for an AIDS<\/p>\n<p>study, will be adapted to the Alzheimers study and may change treatment<\/p>\n<p>protocols. In the AIDS study, MRS examined the pattern and extent of cerebral<\/p>\n<p>injury in HIV infection by monitoring metabolic response to therapies.<\/p>\n<p><P>MRS gives biochemical information about the brain that conventional<\/p>\n<p>methods of analysis cannot provide, and its clinical application has substantially<\/p>\n<p>extended the diagnostic capability of neuroimaging, Dr. McConnell said.<\/p>\n<p><P>In the next 20 years, billions of dollars may be spent on brain imaging<\/p>\n<p>for dementia in the United States, Dr. McConnell said. The added use<\/p>\n<p>of MRS may show us if newer treatments are working. Thats what this research<\/p>\n<p>is all about  improved treatment of patients with dementing diseases.<\/p>\n<p><P>Ten participants are needed for the UNMC study. A small stipend is available.<\/p>\n<p>Basic requirements for the study include early to middle stages of Alzheimers<\/p>\n<p>disease, exhibiting mild to moderate impairment, which include problems<\/p>\n<p>with daily activities such as driving, shopping, keeping a checkbook and<\/p>\n<p>orientation to their surroundings. For more information, call (402) 559-5056.<\/p>\n<p><P>UNMC is the only public academic health science center in the state.<\/p>\n<p>Through its commitment to research, education and patient care, UNMC has<\/p>\n<p>established itself as one of the country&#8217;s leading centers for cancer research<\/p>\n<p>and treatment and solid organ transplantation.&nbsp; More than $34 million<\/p>\n<p>in research grants and contracts are awarded to UNMC scientists annually.&nbsp;<\/p>\n<p>In addition, UNMC&#8217;s educational programs are responsible for training more<\/p>\n<p>health professionals practicing in Nebraska than any other institution.<\/p>\n<p><BR>&nbsp;<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers disease. In the 1960s, the drug was known for causing severe birth defects. It was recently approved by the U.S. Food and Drug Administration as a treatment for a skin condition associated [&hellip;]<\/p>\n","protected":false},"author":79,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-47805","post","type-post","status-publish","format-standard","hentry","category-uncategorized","department-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UNMC Researchers to Study Thalidomide as Treatment for Alzheimer&#039;s Disease<\/title>\n<meta name=\"description\" content=\"The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer&#039;s Disease\" \/>\n<meta property=\"og:description\" content=\"The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unmcedu\" \/>\n<meta property=\"article:published_time\" content=\"1999-01-08T06:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-29T15:59:24+00:00\" \/>\n<meta name=\"author\" content=\"UNMC Today\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@unmc\" \/>\n<meta name=\"twitter:site\" content=\"@unmc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"UNMC Today\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\"},\"author\":{\"name\":\"UNMC Today\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/b7a10902696c45a5370b361e3a9ce621\"},\"headline\":\"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer&#8217;s Disease\",\"datePublished\":\"1999-01-08T06:00:00+00:00\",\"dateModified\":\"2022-08-29T15:59:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\"},\"wordCount\":717,\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\",\"name\":\"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer's Disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\"},\"datePublished\":\"1999-01-08T06:00:00+00:00\",\"dateModified\":\"2022-08-29T15:59:24+00:00\",\"description\":\"The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unmc.edu\/newsroom\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer&#8217;s Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\",\"name\":\"University of Nebraska Medical Center\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"contentUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"width\":500,\"height\":153,\"caption\":\"University of Nebraska Medical Center\"},\"image\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/unmcedu\",\"https:\/\/x.com\/unmc\",\"https:\/\/instagram.com\/iamunmc\",\"https:\/\/www.youtube.com\/user\/UNMCEDU\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/b7a10902696c45a5370b361e3a9ce621\",\"name\":\"UNMC Today\",\"sameAs\":[\"https:\/\/www.unmc.edu\/strategic-communications\"],\"url\":\"https:\/\/www.unmc.edu\/newsroom\/author\/d1fe173d08e959397adf34b1d77e88d7\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer's Disease","description":"The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/","og_locale":"en_US","og_type":"article","og_title":"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer's Disease","og_description":"The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers","og_url":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/unmcedu","article_published_time":"1999-01-08T06:00:00+00:00","article_modified_time":"2022-08-29T15:59:24+00:00","author":"UNMC Today","twitter_card":"summary_large_image","twitter_creator":"@unmc","twitter_site":"@unmc","twitter_misc":{"Written by":"UNMC Today","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/#article","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/"},"author":{"name":"UNMC Today","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/b7a10902696c45a5370b361e3a9ce621"},"headline":"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer&#8217;s Disease","datePublished":"1999-01-08T06:00:00+00:00","dateModified":"2022-08-29T15:59:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/"},"wordCount":717,"publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/","url":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/","name":"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer's Disease","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#website"},"datePublished":"1999-01-08T06:00:00+00:00","dateModified":"2022-08-29T15:59:24+00:00","description":"The University of Nebraska Medical Center has begun a six-month research project to test thalidomide as a possible treatment for people with Alzheimers","breadcrumb":{"@id":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.unmc.edu\/newsroom\/1999\/01\/08\/unmc-researchers-to-study-thalidomide-as-treatmentfor-alzheimers-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unmc.edu\/newsroom\/"},{"@type":"ListItem","position":2,"name":"UNMC Researchers to Study Thalidomide as Treatment for Alzheimer&#8217;s Disease"}]},{"@type":"WebSite","@id":"https:\/\/www.unmc.edu\/newsroom\/#website","url":"https:\/\/www.unmc.edu\/newsroom\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.unmc.edu\/newsroom\/#organization","name":"University of Nebraska Medical Center","url":"https:\/\/www.unmc.edu\/newsroom\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","width":500,"height":153,"caption":"University of Nebraska Medical Center"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/unmcedu","https:\/\/x.com\/unmc","https:\/\/instagram.com\/iamunmc","https:\/\/www.youtube.com\/user\/UNMCEDU"]},{"@type":"Person","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/b7a10902696c45a5370b361e3a9ce621","name":"UNMC Today","sameAs":["https:\/\/www.unmc.edu\/strategic-communications"],"url":"https:\/\/www.unmc.edu\/newsroom\/author\/d1fe173d08e959397adf34b1d77e88d7\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/47805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/users\/79"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/comments?post=47805"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/47805\/revisions"}],"predecessor-version":[{"id":73862,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/47805\/revisions\/73862"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media?parent=47805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/categories?post=47805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/tags?post=47805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}